|
|||||
![]() |
|
![]() | |||||||||||||||||||||||||||||
Group: | Order: | Settings | |||||||||||||||||||||||||||
![]() |
No. | Name | Market Cap. | P/E | Forward P/E | PEG | P/S | P/B | P/Cash | P/Free Cash Flow |
Dividend Yield | EPS growth past 5 years | EPS growth next 5 years | Sales growth past 5 years | Float Short | Performance (Week) | Performance (Month) | Performance (Quarter) | Performance (Half Year) | Performance (Year) |
Performance (Year To Date) | Analyst Recom. | Average Volume | Relative Volume | Change | Volume | Number of Stocks |
Overview | Valuation | Performance | Custom | Bar Chart | Spectrum | Charts |
No. | Name | Market Cap | P/E | P/B | P/C | Dividend | EPS past 5Y | EPS next 5Y | Perf Half | Avg Volume | Change | Stocks |
1 | Communication Services | 5912.21B | 20.87 | 2.50 | 13.44 | 0.95% | 18.12% | 13.11% | -5.73% | 791.27M | -1.29% | 291 |
2 | Technology | 12092.56B | 28.73 | 6.26 | 16.11 | 1.00% | 23.98% | 12.96% | -5.73% | 1.44B | -1.43% | 786 |
3 | Consumer Cyclical | 6393.92B | 23.84 | 3.94 | 9.82 | 0.89% | 9.50% | 21.09% | -5.89% | 1.69B | -0.58% | 576 |
4 | Industrials | 4898.94B | 20.71 | 3.65 | 15.42 | 1.61% | 16.16% | 12.01% | 5.28% | 531.13M | -0.63% | 652 |
5 | Real Estate | 1593.38B | 25.28 | 2.26 | 25.14 | 3.64% | 10.86% | 8.50% | -5.69% | 314.77M | -0.98% | 270 |
6 | Financial | 9322.07B | 14.48 | 1.57 | 0.53 | 2.26% | 19.55% | 8.03% | 7.05% | 863.91M | -0.68% | 1113 |
7 | Consumer Defensive | 3677.51B | 24.98 | 4.30 | 22.91 | 2.58% | 7.80% | 7.27% | -0.13% | 314.67M | -0.27% | 248 |
8 | Healthcare | 7468.88B | 25.48 | 4.12 | 11.86 | 1.57% | 15.23% | 9.06% | -0.19% | 1.21B | -0.44% | 1305 |
9 | Utilities | 1477.11B | 22.34 | 1.03 | 35.49 | 3.51% | 2.40% | 8.09% | -7.53% | 148.11M | -0.00% | 114 |
10 | Basic Materials | 2101.67B | 9.88 | 2.01 | 12.13 | 3.61% | 25.75% | 3.71% | 12.41% | 399.52M | -1.40% | 256 |
11 | Energy | 3525.48B | 7.01 | 1.60 | 10.25 | 6.95% | 40.00% | 15.54% | 10.91% | 546.89M | -0.63% | 268 |
export |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite